Selected populations at increased risk from respiratory syncytial virus infection

scientific article

Selected populations at increased risk from respiratory syncytial virus infection is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1097/00006454-200302001-00006
P698PubMed publication ID12671451

P2093author name stringH Cody Meissner
P433issue2 Suppl
P304page(s)S40-4; discussion S44-5
P577publication date2003-02-01
P1433published inPediatric Infectious Disease JournalQ15756717
P1476titleSelected populations at increased risk from respiratory syncytial virus infection
P478volume22

Reverse relations

cites work (P2860)
Q40117278A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease
Q38837433Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches.
Q34313560Animal pneumoviruses: molecular genetics and pathogenesis
Q36523253Antimicrobial therapy in childhood asthma and wheezing.
Q40191355Associations of Nasopharyngeal Metabolome and Microbiome with Severity Among Infants with Bronchiolitis: A Multi-omic Analysis
Q59354281Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO)
Q22241278Epidemiology and etiology of childhood pneumonia
Q40287752Epidemiology of 11 respiratory RNA viruses in a cohort of hospitalized children in Riyadh, Saudi Arabia
Q40283024Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman.
Q42210332Etiology of acute bronchiolitis and the relationship with meteorological conditions in hospitalized infants in China
Q35950212Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia
Q34120191Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.
Q24202303Glucocorticoids for acute viral bronchiolitis in infants and young children
Q35857662Host transcription profiles upon primary respiratory syncytial virus infection
Q45417824Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections
Q40430519Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
Q40043100Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines
Q91910118Improving Evidence Based Bronchiolitis Care
Q39442518Incidence of Respiratory Disease During the First Two Years of Life in Children with Hemodynamically Significant Congenital Heart Disease in Italy: A Retrospective Study
Q45394767Medical retrieval and needs of infants with bronchiolitis: an analysis by gestational age.
Q47271049Nebulised hypertonic saline solution for acute bronchiolitis in infants.
Q27002560Recent advances in management of bronchiolitis
Q36145000Reducing the impact of viral respiratory infections in children
Q35526996Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?
Q38694691Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.
Q36361899Respiratory syncytial virus bronchiolitis
Q45399642Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database
Q40298671Respiratory syncytial virus infection in children with neuromuscular impairment
Q38968287Respiratory syncytial virus infections in Central Australia.
Q33591243Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology
Q24655957Respiratory viruses other than influenza virus: impact and therapeutic advances
Q90109697Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013)
Q54265000Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department.
Q37669850Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults
Q33312377Sensitive commercial NASBA assay for the detection of respiratory syncytial virus in clinical specimen
Q26766723Stable long-term cultures of self-renewing B cells and their applications
Q33952463Systemic signature of the lung response to respiratory syncytial virus infection
Q36411968Treatment of respiratory virus infections

Search more.